From memory they had a toenail fungus product in market in partnership with Sandoz/Novartis which had been out for a couple of years before they got through the P3 trials with the AD drug. When I've got some time later I'll try and dig out more. But you're right in that Pfizer's main attraction to Anacor was the AD drug, and also correct that they were not actively developing anything in the AMR space. Cheers
- Forums
- ASX - By Stock
- BOT
- hope this is going to ring true.
hope this is going to ring true., page-11
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M |
Open | High | Low | Value | Volume |
38.0¢ | 38.5¢ | 36.5¢ | $2.548M | 6.766M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 96148 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.0¢ | 782479 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 95890 | 0.365 |
7 | 391832 | 0.360 |
5 | 284373 | 0.355 |
5 | 297700 | 0.350 |
3 | 610000 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.370 | 766484 | 7 |
0.375 | 110000 | 1 |
0.380 | 1003076 | 7 |
0.385 | 428298 | 8 |
0.390 | 621135 | 23 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |